These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15618958)

  • 21. Aml1 gene rearrangements and mutations in radiation-associated acute myeloid leukemia and myelodysplastic syndromes.
    Klymenko S; Trott K; Atkinson M; Bink K; Bebeshko V; Bazyka D; Dmytrenko I; Abramenko I; Bilous N; Misurin A; Zitzelsberger H; Rosemann M
    J Radiat Res; 2005 Jun; 46(2):249-55. PubMed ID: 15988144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatic point mutations in RUNX1/CBFA2/AML1 are common in high-risk myelodysplastic syndrome, but not in myelofibrosis with myeloid metaplasia.
    Steensma DP; Gibbons RJ; Mesa RA; Tefferi A; Higgs DR
    Eur J Haematol; 2005 Jan; 74(1):47-53. PubMed ID: 15613106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loci other than 21q22.12 (RUNX1) and 16q21-23.2 cause familial AML.
    Sellick GS; Pritchard-Jones K; Shepherd V; Swansbury J; Catovsky D; Houlston RS
    Leukemia; 2005 Mar; 19(3):465-6. PubMed ID: 15674419
    [No Abstract]   [Full Text] [Related]  

  • 24. Dual mutations in the AML1 and FLT3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtype.
    Matsuno N; Osato M; Yamashita N; Yanagida M; Nanri T; Fukushima T; Motoji T; Kusumoto S; Towatari M; Suzuki R; Naoe T; Nishii K; Shigesada K; Ohno R; Mitsuya H; Ito Y; Asou N
    Leukemia; 2003 Dec; 17(12):2492-9. PubMed ID: 14562119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia.
    Harada H; Harada Y; Niimi H; Kyo T; Kimura A; Inaba T
    Blood; 2004 Mar; 103(6):2316-24. PubMed ID: 14615365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amplification of AML1 gene in association with karyotype, age and diagnosis in acute leukemia patients.
    Kirschnerová G; Tóthová A; Babusíková O
    Neoplasma; 2006; 53(2):150-4. PubMed ID: 16575471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Williams-Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETO.
    Fliegauf M; Stock M; Berg T; Lübbert M
    Oncogene; 2004 Dec; 23(56):9070-81. PubMed ID: 15489901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene.
    Yergeau DA; Hetherington CJ; Wang Q; Zhang P; Sharpe AH; Binder M; Marín-Padilla M; Tenen DG; Speck NA; Zhang DE
    Nat Genet; 1997 Mar; 15(3):303-6. PubMed ID: 9054947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations of AML1 are common in therapy-related myelodysplasia following therapy with alkylating agents and are significantly associated with deletion or loss of chromosome arm 7q and with subsequent leukemic transformation.
    Christiansen DH; Andersen MK; Pedersen-Bjergaard J
    Blood; 2004 Sep; 104(5):1474-81. PubMed ID: 15142876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia.
    Harada H; Harada Y; Tanaka H; Kimura A; Inaba T
    Blood; 2003 Jan; 101(2):673-80. PubMed ID: 12393679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of t(3 ; 21) (q26 ; q22) with AML1/EVI1 mRNA during progression of myelodysplastic syndrome to acute myeloid leukemia].
    Choi I; Goto T; Nagano M; Muta K; Yufu Y; Uike N; Kozuru M; Abe Y; Nisimura J
    Rinsho Ketsueki; 1999 Jun; 40(6):518-20. PubMed ID: 10422292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia.
    Martínez-Ramírez A; Urioste M; Contra T; Cantalejo A; Tavares A; Portero JA; López-Ibor B; Bernacer M; Soto C; Cigudosa JC; Benítez J
    Haematologica; 2001 Dec; 86(12):1245-53. PubMed ID: 11726315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
    Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
    Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanisms that produce secondary MDS/AML by RUNX1/AML1 point mutations.
    Harada Y; Harada H
    J Cell Biochem; 2011 Feb; 112(2):425-32. PubMed ID: 21268063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial platelet disorder with propensity to acute myelogenous leukemia: genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies.
    Minelli A; Maserati E; Rossi G; Bernardo ME; De Stefano P; Cecchini MP; Valli R; Albano V; Pierani P; Leszl A; Sainati L; Lo Curto F; Danesino C; Locatelli F; Pasquali F
    Genes Chromosomes Cancer; 2004 Jul; 40(3):165-71. PubMed ID: 15138996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1.
    Nucifora G; Begy CR; Erickson P; Drabkin HA; Rowley JD
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7784-8. PubMed ID: 8395054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analyses of the mutations of AML 1 gene in myelodysplastic syndromes].
    Yoichi I
    Rinsho Ketsueki; 2002 Mar; 43(3):139-45. PubMed ID: 11979742
    [No Abstract]   [Full Text] [Related]  

  • 38. Identical fusion transcript associated with different breakpoints in the AML1 gene in simple and variant t(8;21) acute myeloid leukemia.
    de Greef GE; Hagemeijer A; Morgan R; Wijsman J; Hoefsloot LH; Sandberg AA; Sacchi N
    Leukemia; 1995 Feb; 9(2):282-7. PubMed ID: 7869765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML.
    Licht JD
    Oncogene; 2001 Sep; 20(40):5660-79. PubMed ID: 11607817
    [No Abstract]   [Full Text] [Related]  

  • 40. Chromosome 21 tandem repetition and AML1 (RUNX1) gene amplification.
    Ferro MT; Hernaez R; Sordo MT; Garcia-Sagredo JM; Garcia-Miguel P; Fernández Guijarro M; Lopez J; Villalón C; Vallcorba I; Cabello P; San Roman C
    Cancer Genet Cytogenet; 2004 Feb; 149(1):11-6. PubMed ID: 15104277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.